Table 2.
Reference |
Total N |
Total prevalence (%) |
Male prevalence (%) |
Female prevalence (%) |
---|---|---|---|---|
Male N/Female N | (CI 95%) | (CI 95%) | (CI 95%) | |
Brandão et al. 1996 [15] |
3906 |
8.7(7.89-9.66) |
NI |
NI |
Candido et al. 2009 [18] |
487 |
3.3* |
3.8* |
2.8* |
236/251 |
(2.03-5.31) |
(1.99-7.15) |
(1.34-5.74) |
|
Chaves et al. 2006 [20] |
179 |
20.1 |
NI |
NI |
90/89 |
(14.86-26.61) |
|
|
|
Christofaro et al. 2010 [22] |
233 |
12.4 |
10.6 |
14.2 |
120/113 |
(8.75-17.28) |
(6.22-17.49) |
(8.90-21.91) |
|
Costa et al. 1998 [16] |
646 |
8.9* |
10.9 |
7 |
332/314 |
(6.94-11.35) |
(7.97-14.73) |
(4.65-10.40) |
|
Da Silva et al. 2007 [4] |
674 |
7.4 |
10.2 |
5.1 |
303/371 |
(5.65-9.64) |
(7.26-14.14) |
(3.27-7.86) |
|
De Campos et al. 2010 [24] |
497 |
12.6* |
13.8 |
11.5 |
260/237 |
(9.96-15.81) |
(10.11-18.55) |
(8.02-16.22) |
|
Gomes et al. 2009 [25] |
1878 |
17.3 |
24 |
13* |
738/1140 |
(15.65-19.07) |
(21.05-27.21) |
(11.17-15.08) |
|
Monego et al. 2006 [27] |
2118 |
2.9* |
2.8* |
3.1* |
1052/1066 |
(2.26-3.71) |
(1.95-3.98) |
(4.41-8.96) |
|
Moura et al. 2004 [28] |
898 |
10.6* |
11.8* |
9.6* |
380/518 |
(8.75-12.79) |
(8.92-15.44) |
(7.34-12.45) |
|
Paixão et al. 2009 [30] |
71 |
4.2 |
9 |
0 |
33/38 |
(1.36-12.26) |
(3.00-24.57) |
(0.005-31.30) |
|
Peters et al. 2009 [31] |
205 |
12.2 |
NI |
NI |
106/99 |
(8.37-17.42) |
|
|
|
Rodrigues et al. 2006 [32] |
380 |
3.4 |
3.4 |
3.4 |
177/203 |
(1.98-5.78) |
(1.54-7.35) |
(1.62-7.00) |
|
Roelofs et al. 2010 [33] |
1002 |
14.7* |
17 |
12.9 |
442/560 |
(12.64-17.03) |
(13.77-20.80) |
(10.36-15.94) |
|
Rosa et al. 2007 [34] |
456 |
4.6 |
5.9 |
3.6 |
203/253 |
(3.02-6.95) |
(3.38-10.10) |
(1.90-6.74) |
|
Silva et al. 2008 [35] |
704 |
9.5 |
NI |
NI |
333/371 |
(7.56-11.92) |
|
|
|
Souza et al. 2006 [36] | 302 |
2.7 |
6.1 |
1.1* |
95/207 | (1.36-5.27) | (2.73-13.09) | (0.30-3.94) |
NI – No Information * Calculated values CI – Confidence Interval.